证券代码：301363 证券简称：美好医疗 公告编号：2025-049 深圳市美好创亿医疗科技股份有限公司 2025年第一次临时股东大会决议公告 2、现场会议召开地点：广东省惠州市大亚湾西区龙山三路318号美好创亿产 业园A栋8楼801会议室 3、网络投票时间：2025年8月11日（星期一）。其中，通过深圳证券交易所 交易系统进行网络投票的时间为2025年8月11日上午9:15-9:25、9:30-11:30、下 午13:00-15:00；通过深圳证券交易所互联网投票系统进行网络投票的时间为 2025年8月11日9:15-15:00期间的任意时间。 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 特别提示： 1、本次股东大会未出现变更或否决议案的情形； 2、本次股东大会不涉及变更前次股东大会决议； 3、本次股东大会采用现场表决与网络投票相结合的方式召开。 一、会议召开和出席情况 深圳市美好创亿医疗科技股份有限公司（以下简称"公司"）2025年第一次 临时股东大会（以下简称"本次股东大会"）于2025年8月11日（星期一）下午 15:30召开，公司已于2025年 ...

Core Viewpoint - The brain-computer interface (BCI) industry is expected to experience significant growth, with 2023 being a pivotal year for its development and application across various sectors [2][8]. Group 1: Market Performance - The BCI concept stocks have seen a strong rally, with several companies like Sainuo Medical, Guangdian Co., and Shangrong Medical hitting their daily price limits [4]. - Notable stock performances include Lide Man and Botuo Bio, which rose over 11%, and Meilan De, which increased by 10% [4]. Group 2: Technological Advancements - BCI technology connects the brain with external devices for information exchange, showing promise in medical fields such as disease diagnosis and treatment [6]. - Significant advancements have been made in BCI technology, particularly in biomedical applications, neuro-rehabilitation, and intelligent robotics [6]. Group 3: Industry Outlook - According to McKinsey, the global market for BCI medical applications is projected to reach $40 billion by 2030 and $145 billion by 2040 [7]. - The Chinese BCI industry, although starting late, is rapidly developing, with multiple policies introduced since 2025 to support its growth [9][10]. Group 4: Policy Support - Recent government initiatives aim to accelerate the commercialization of BCI technology, with specific action plans released by cities like Beijing and Shanghai [9][10]. - The Ministry of Industry and Information Technology and other departments have set ambitious goals for the BCI industry over the next five years, focusing on technological breakthroughs and establishing a robust industrial ecosystem [10]. Group 5: Application Areas - The BCI industry has two primary application areas: serious medical applications, such as rehabilitation for stroke and spinal injury patients, and consumer applications addressing issues like sleep disorders [11]. - A significant challenge for the industry is to reduce costs, making BCI technologies more accessible to the general public [11][12].

Group 1 - The core viewpoint of the articles highlights the performance and valuation of Meihao Medical, which closed at 20.03 yuan, up 7.17%, with a rolling PE ratio of 31.86, marking a new low in 48 days, and a total market capitalization of 11.394 billion yuan [1] - In comparison to the industry, Meihao Medical's PE ratio of 31.86 is significantly lower than the industry average of 55.70 and the median of 39.08, ranking 65th in the medical device sector [1][2] - As of July 31, 2025, Meihao Medical has 13,185 shareholders, an increase of 87 from the previous count, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares [1] Group 2 - Meihao Medical specializes in the design, development, manufacturing, and sales of precision components and products for medical devices, including home ventilator components and cochlear implant components [1] - The latest quarterly report for Q1 2025 shows that the company achieved a revenue of 296 million yuan, a year-on-year increase of 5.05%, while net profit was 51.875 million yuan, reflecting a year-on-year decrease of 10.62%, with a gross profit margin of 39.28% [1]

来源：金融界 主力资金净流出居前的分别为安必平（1174.99万元）、东富龙（1070.65万元）、安杰思（995.13万 元）、微电生理（983.9万元）、可孚医疗（916.41万元）。 序号代码名称最新价涨跌幅主力净流入主力净占比1300760迈瑞医疗230.71-0.031.07亿元7.18%2300003 乐普医疗17.276.931.07亿元5.73%3301363美好医疗20.037.175599.57万元11.04%4603987康德莱 9.235.734851.48万元12.43%5870199倍益康42.581.383949.32万元7.52%6002551尚荣医疗4.649.953736.73 万元22.93%7688068热景生物243.022.543614.97万元6.9%8688314康拓医疗40.08.113278.73万元 15.1%9688108赛诺医疗20.4420.022762.62万元19.98%10832278鹿得医疗12.484.962727.93万元13.05% 8月8日，医疗器械行业上涨0.93%，今日主力资金流出6.11亿元，成分股59只上涨，39只下跌。 ...

Market Overview - The Shanghai Composite Index closed at 3642.10 points, above the six-month moving average, with a slight increase of 0.07% [1] - The total trading volume of A-shares reached 1,093.29 billion yuan [1] Stocks Breaking the Six-Month Moving Average - A total of 54 A-shares have surpassed the six-month moving average today [1] - Notable stocks with significant deviation rates include: - Meihao Medical (301363) with a deviation rate of 7.64% and a daily increase of 7.54% [1] - Fushi Holdings (300071) with a deviation rate of 3.55% and a daily increase of 4.53% [1] - Chengdi Xiangjiang (603887) with a deviation rate of 3.19% and a daily increase of 7.92% [1] Detailed Stock Performance - The following stocks have notable performance metrics: - Meihao Medical: Latest price 20.10 yuan, half-year line 18.67 yuan, turnover rate 13.18% [1] - Fushi Holdings: Latest price 5.54 yuan, half-year line 5.35 yuan, turnover rate 11.78% [1] - Chengdi Xiangjiang: Latest price 18.66 yuan, half-year line 18.08 yuan, turnover rate 8.21% [1] - Other stocks with smaller deviation rates include: - Bihai Source (300829) with a deviation rate of 2.77% [1] - Zhisheng Information (832171) with a deviation rate of 2.31% [1] - Zhonggang International (000928) with a deviation rate of 1.91% [1]

Group 1: A-share Market Performance - The A-share market experienced narrow fluctuations, with the Shanghai Composite Index slightly increasing by 0.07% and the Shenzhen Component Index rising by 0.14% [2] - The brain-computer interface (BCI) concept sector saw significant gains, with the Wind BCI Index rising over 3% during trading [5][6] - Notable stocks in the BCI sector included Sino Medical, which hit a 20% limit up, and other companies like Optoelectronics and Lepu Medical also saw substantial increases [5][6] Group 2: Brain-Computer Interface Industry Insights - The Ministry of Industry and Information Technology and other governmental bodies released an implementation opinion to promote the high-quality development of the BCI industry [6][7] - The implementation opinion emphasizes the integration of biological intelligence and machine intelligence, aiming for breakthroughs in key technologies by 2027 [7] - The BCI sector is positioned as a critical area for technological and industrial innovation, with expectations for a robust production and standards system [7] Group 3: New Stock Listings - Two new stocks were listed on the A-share market, both experiencing significant price increases, with Youli Intelligent rising over 300% and Tianfulong increasing by over 240% during trading [8][10] - Youli Intelligent specializes in photovoltaic support structures, while Tianfulong focuses on differentiated polyester short fibers and new materials for solar panel protection [9][12] Group 4: Hong Kong Market Performance - The Hong Kong market showed a lackluster performance, with the Hang Seng Index falling below the 25,000-point mark [13] - Among the constituents, stocks like Kowloon Warehouse and SMIC saw notable declines, while companies such as CSPC Pharmaceutical and China Hongqiao led the gains [14] - Dongfeng Group's shares surged by over 14% despite a profit warning indicating a significant expected decline in net profit for the first half of the year [15]

证券时报·数据宝统计，截至今日上午10:29，上证综指3636.69点，收于半年线之上，涨跌幅-0.08%，A 股总成交额为8029.00亿元。到目前为止，今日有38只A股价格突破了半年线，其中乖离率较大的个股有 美好医疗、福石控股、金丹科技等，乖离率分别为8.17%、3.74%、3.27%；碧水源、京山轻机、华能水 电等个股乖离率较小，刚刚站上半年线。 8月8日突破半年线个股乖离率排名 | 证券代 | 证券简 | 今日涨跌幅 | 今日换手率 | 半年线 | 最新价 | 乖离率 | | --- | --- | --- | --- | --- | --- | --- | | 码 | 称 | （%） | （%） | （元） | （元） | （%） | | 301363 | 美好医 | 8.08 | 9.06 | 18.67 | 20.20 | 8.17 | | | 疗 | | | | | | | 300071 | 福石控 股 | 4.72 | 10.77 | 5.35 | 5.55 | 3.74 | | 300829 | 金丹科 技 | 4.28 | 6.77 | 17.94 | 18.53 | 3.27 | | ...

医疗器械 ETF（562600）为投资者提供一键把握医疗器械行业成长机遇的便捷工具。该ETF追踪的中证 全指医疗器械指数，精心选取 100 支覆盖医疗器械、医疗服务、医疗信息化等核心医疗领域的代表性上 市公司证券作为样本。按wind脑机接口指数测算，截至2025年8月6日指数含脑机接口权重21.9%，从行 业结构看，该指数医疗器械行业占比高达 89.08%，集中度突出，能精准捕捉医疗器械领域的发展红 利。感兴趣的投资者可以持续关注。 （文章来源：每日经济新闻） 提出到2027年、2030年两步走发展目标，明确五大重点任务，细化17项具体举措，进一步推动脑机接口 产业高质量发展。这一重磅文件的出台，为我国脑机接口产业的未来发展描绘了清晰的蓝图，有望在全 球科技竞争中抢占先机，培育出具有国际竞争力的未来产业新赛道。 受此影响，医疗器械板块持续活跃，医疗器械ETF短暂调整后直线拉升，发稿时涨超1%。持仓股票赛 诺医疗20厘米涨停，利德曼、麦澜德、尚荣医疗、美好医疗涨幅居前。 消息面，工业和信息化部、国家发展改革委等7 部门发布关于推动脑机接口产业创新发展的实施意见。 ...

证券日报网讯美好医疗（301363）8月4日在互动平台回答投资者提问时表示，截至2025年7月31日，公 司股东总数为13185户。 ...

从8月4日公开信息显示，美好医疗截至2025年7月31日公司股东户数为1.32万户，较上期（2025年7月18日）增加87户，增幅 为0.66%，变化不大。 从数据对比来看，美好医疗户均持股数从上期4.34万股下降至本期4.31万股，户均持股市值从上期80.70万元下降至本期79.69 万元。上述区间，美好医疗股价累计下跌0.96%。 截至发稿，美好医疗报18.61元，下跌0.16%，市值105.87亿元。 最新5个统计日期，美好医疗股东户数变动如下： 统计日期股东户数户均持股数（万股）户均持股市值（万元） 2025/07/31131854.3179.692025/07/18130984.3480.702025/06/30124874.5680.362025/06/10123024.6281.622025/05/30112653.6185.34 来源：金融界 ...